Compare AbbVie Inc (ABBV) vs Direxion Daily CSI China Internet Bull 2X Shares (CWEB) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbbVie Inc vs Direxion Daily CSI China Internet Bull 2X Shares — how do they compare? AbbVie Inc trades at $253.75 (market cap $449.91B), while Direxion Daily CSI China Internet Bull 2X Shares trades at $22.02. The key difference: AbbVie Inc pays a 2.72% dividend while Direxion Daily CSI China Internet Bull 2X Shares pays none, and AbbVie Inc is trading nearer its 52-week high, Direxion Daily CSI China Internet Bull 2X Shares nearer its low. Which is the better fit depends on your goals.
| ABBV | CWEB | |
|---|---|---|
Market Cap | $449.91B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $261.07 | $60.13 |
52-Week Low | $184.85 | $17.70 |
Enterprise Value | $513.38B | — |
Dividend Yield | 2.72% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbbVie (ABBV) trades at $252.92, down 0.72% on the day, with strong technical support at $251 and resistance at $258. The stock shows bullish momentum with recent earnings beats and a consensus analyst price target of $266.33. Revenue grew to $61.16B in 2025, though net margins compressed to 5.79%. Key growth drivers include Skyrizi and Rinvoq offsetting Humira declines, supported by positive Phase 2 data for ELAHERE in ovarian cancer (PRNewsWire, 2026-04-12).
Outlook remains positive with immunology portfolio strength and dividend growth, but risks include patent cliffs in the 2030s and high debt levels. Institutional buying and 68% analyst buy ratings suggest confidence, though valuation multiples like P/E of 124.83 warrant caution. Near-term catalysts include Q2 2026 earnings expected at $3.79 EPS.
CWEB stock is trading at $20.66, up 5.09% with a bullish technical signal supported by moving averages. The stock shows mixed momentum with RSI indicators suggesting both overbought and neutral conditions. Recent corporate action includes a $0.09 dividend scheduled for June 2026. Trading activity indicates strong interest with the current price near pivot point resistance levels.
The stock's technical strength contrasts with limited fundamental data availability. Investment appeal hinges on upcoming financial disclosures to validate current market positioning. Key risks include reliance on technical momentum without clear fundamental support and market volatility affecting short-term price action.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Read more on ABBV →About Direxion Daily CSI China Internet Bull 2X Shares
CWEB is a leveraged ETF that seeks to provide two times (2x) the daily performance of the CSI China Internet Index. It offers magnified exposure to top Chinese internet companies listed on US and Hong Kong exchanges.
Read more on CWEB →
